Search Results 2511-2520 of 25027 for oral

1. Safety and Efficacy of GS-5745 in Participants With Moderately to Severely Active Crohn's Disease - Mayo Clinic

   Participation eligibility · Oral 5-aminosalicylate (5-ASA) · Oral corticosteroid therapy · Antidiarrheals for chronic diarrhea · Azathioprine or 6-mercaptopurine (6 ...

2. Fecal Microbiota Clinical Trials - Mayo Clinic Research

   ... oral antibiotic therapy or have had at least two episodes of severe CDI resulting in hospitalization may be eligible for the study. Subjects may receive a ...

3. Fecal Microbiota (Stool Clinical Trials - Mayo Clinic Research

   ... oral antibiotic therapy or have had at least two episodes of severe CDI resulting in hospitalization may be eligible for the study. Subjects may receive a ...

4. Pulling Problem Teeth Before Heart Surgery to Prevent Infection May Be Catch-22 - Mayo Clinic News Network

   The co-authors are anesthesiologists David Barbara, M.D., and William Mauermann, M.D.; Christopher Viozzi, D.D.S., M.D., an oral and maxillofacial surgeon ...

5. A Study to Investigate Efficacy and Safety of TOUR006 in Participants 18 to 75 Years of Age With Thyroid Eye Disease - Mayo Clinic

   * History of systemic (eg, oral or IV) steroid use with a cumulative dose equivalent to \>1 g of methylprednisolone for the treatment of TED. Previous oral ...

6. A First in Man Trial for Patients With Cancer - Mayo Clinic

   Inability to swallow oral meds or gastrointestinal disorder that might interfere with absorption of oral drugs; Major surgery within 28 days of first receipt ...

7. A Study of the Safety and Effectiveness of GS-5745 in Participants with Moderately to Severely Active Crohn's Disease - Mayo Clinic

   Participation eligibility · Oral 5-aminosalicylate (5-ASA) · Oral corticosteroid therapy · Antidiarrheals for chronic diarrhea · Azathioprine or 6-mercaptopurine (6 ...

8. Scott C. Calder, D.O. - Doctors and Medical Staff - Mayo Clinic

   2025. ProctorOral Board Review Course, American Academy of Emergency Medicine · 2024 - present. MemberStroke Steering Committee, Mayo Clinic Arizona Committees.

9. A Study to Evaluate the Safety and Effectiveness of NX9 for CT Imaging in Patients with Cancer or GI Disease - Mayo Clinic

   The purpose of this study is to collect safety, effectiveness and pharmacokinetics (in a subgroup of subjects) data on the use of NX9 as an oral CT contrast ...

10. Head and neck cancers - Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric and Adolescent Medicine · Pediatric Otolaryngology · Physical Medicine ...